Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Safety Ratings 11,700+ NHTSA crash test ratings Investigations 5,300+ NHTSA defect investigations Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports Brand History Cross-category recall lookup by company
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents State Safety Dashboards Safety grades for all 50 U.S. states ZIP Safety Report Check any 5-digit ZIP across 9 datasets
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases
Blog

Vehicle Safety

Vehicle Recalls320,000+ NHTSA safety recalls Browse VehiclesEvery make, model and year Complaints2.1M+ consumer safety complaints TSBs4.7M technical service bulletins VIN LookupDecode any vehicle VIN instantly OBD Codes12,000+ diagnostic trouble codes Fuel EconomyEPA MPG data for all vehicles Safety Ratings11,700+ NHTSA crash test ratings Investigations5,300+ NHTSA defect investigations StatisticsRecall trends & safety analysis Compare VehiclesTwo vehicles side by side

Consumer Safety

Product Safety9,700+ CPSC product recalls Food Safety28,600+ FDA food recalls Pet Safety1.3M FDA animal adverse events Drug Safety17,500+ FDA drug recalls Device Safety38,400+ FDA device recalls Workplace Safety102,900+ OSHA injury reports Brand HistoryRecall lookup by company

Infrastructure

Bridge Safety624,000 bridge inspections Aviation Safety30,000+ NTSB aviation events Dam Safety92,600 dam safety records Water Safety433,000+ public water systems Railroad Safety438,000+ rail crossings Pipeline Safety8,800+ pipeline incidents State DashboardsSafety grades for all 50 states ZIP ReportAny 5-digit ZIP across 9 datasets

Public Health

Nursing Homes14,700 CMS rated facilities Environmental80,000+ hazardous sites & releases BlogGuides, news & safety insights

Browse Drug Recalls

14,572 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 14,572 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 14,572 FDA drug recalls, Class II.

Clear
DateProductReasonClassFirm
Jul 16, 2026 Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5... Presence of Particulate Matter: Hair was found in products Class II Fresenius Kabi USA, LLC
Jul 14, 2026 Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precisi... Failed Impurities/Degradation Specifications Class II Precision Dose Inc.
Jul 14, 2026 Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Ster... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polyso... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Ster... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polyso... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 14, 2026 Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polyso... Lack of Assurance of Sterility Class II Rohto-Mentholatum (Vietnam) Co., Ltd.
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 ... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx o... Presence of Precipitate: medication was crystallizing and particles floating in the bottle Class II Rising Pharma Holding, Inc.
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) uni... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 ... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 ... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) uni... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 un... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 un... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) u... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 un... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 un... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) u... Subpotent Drug Class II Major Pharmaceuticals
Jul 13, 2026 Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) uni... Subpotent Drug Class II Major Pharmaceuticals
Jul 9, 2026 BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopro... Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the pa... Class II CareFusion 213, LLC
Jul 8, 2026 Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bott... Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications Class II Ascend Laboratories, LLC
Jul 6, 2026 CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Sing... Lack of Assurance of Sterility Class II Chiesi USA, Inc.
Jul 2, 2026 Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 via... Presence of precipitate Class II MYLAN PHARMACEUTICALS INC
Jun 29, 2026 Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactur... cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Class II Cipla USA, Inc.
Jun 29, 2026 Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactur... cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Class II Cipla USA, Inc.
Jun 29, 2026 Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactur... cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Class II Cipla USA, Inc.
Jun 26, 2026 Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, ... Presence of Foreign Tablets/Capsules Class II Bionpharma Inc.
Jun 26, 2026 Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphet... Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER ... Class II Lannett Company Inc.
Jun 25, 2026 Foster & Thrive, Carbamide Peroxide 6.5%, 0.5 FL OZ (15 mL), NDC 70677-1154-0... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 GOOD NEIGHBOR PHARMACY, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL), a) Kit - ... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 AUDIOLOGIST'S CHOICE, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL) a) Kit - Was... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 TopCare Health, CARBAMIDE PEROXIDE 6.5%, 0.5 FL OZ (15 mL) a) Kit - WASHER BU... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 CVS Health, Carbamide Peroxide, 6.5%, 0.5 FL Oz (15 mL), a) Bottle (NDC 51316... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 meijer, Carbamide Peroxide 6.5%, 0.5 FL OZ (15 mL), Washer Bulb included, NDC... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 CAREone, Carbamide Peroxide 6.5%, 0.5 FL OZ (15 mL), Bottle, NDC 72476-838-34... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 FAMILY Wellness, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL), Kit - Washer Bul... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 LEADER, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL), a) Kit -1 RUBBER BULB SYR... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x ... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 25, 2026 QC Quality Choice, Carbamide Peroxide, 6.5%, 0.5 FL. OZ. (15 mL) a) Washer Bu... SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Class II Bell Pharmaceuticals, Inc
Jun 24, 2026 Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, C... Failed Impurities/Degradation Specifications Class II QuVa Pharma, Inc.
Jun 24, 2026 Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, Fo... Lack of Sterility Assurance Class II Reliance Life Sciences Private Limited
Jun 24, 2026 Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For... Lack of Sterility Assurance Class II Reliance Life Sciences Private Limited
Jun 24, 2026 Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intraven... Lack of Sterility Assurance Class II Reliance Life Sciences Private Limited
Jun 24, 2026 Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For... Lack of Sterility Assurance Class II Reliance Life Sciences Private Limited
Jun 23, 2026 Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g ... Subpotent Drug: Low out of specification assay results performed during long-term stability testing. Class II Padagis US LLC
Jun 23, 2026 Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg p... CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long... Class II Lupin Pharmaceuticals Inc.

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.